Literature DB >> 28053028

Activation of Pedunculopontine Glutamate Neurons Is Reinforcing.

Ji Hoon Yoo1, Vivien Zell1, Johnathan Wu1, Cindy Punta1, Nivedita Ramajayam1, Xinyi Shen1, Lauren Faget1, Varoth Lilascharoen2, Byung Kook Lim2, Thomas S Hnasko3.   

Abstract

Dopamine transmission from midbrain ventral tegmental area (VTA) neurons underlies behavioral processes related to motivation and drug addiction. The pedunculopontine tegmental nucleus (PPTg) is a brainstem nucleus containing glutamate-, acetylcholine-, and GABA-releasing neurons with connections to basal ganglia and limbic brain regions. Here we investigated the role of PPTg glutamate neurons in reinforcement, with an emphasis on their projections to VTA dopamine neurons. We used cell-type-specific anterograde tracing and optogenetic methods to selectively label and manipulate glutamate projections from PPTg neurons in mice. We used anatomical, electrophysiological, and behavioral assays to determine their patterns of connectivity and ascribe functional roles in reinforcement. We found that photoactivation of PPTg glutamate cell bodies could serve as a direct positive reinforcer on intracranial self-photostimulation assays. Further, PPTg glutamate neurons directly innervate VTA; photostimulation of this pathway preferentially excites VTA dopamine neurons and is sufficient to induce behavioral reinforcement. These results demonstrate that ascending PPTg glutamate projections can drive motivated behavior, and PPTg to VTA synapses may represent an important target relevant to drug addiction and other mental health disorders. SIGNIFICANCE STATEMENT: Uncovering brain circuits underlying reward-seeking is an important step toward understanding the circuit bases of drug addiction and other psychiatric disorders. The dopaminergic system emanating from the ventral tegmental area (VTA) plays a key role in regulating reward-seeking behaviors. We used optogenetics to demonstrate that the pedunculopontine tegmental nucleus sends glutamatergic projections to VTA dopamine neurons, and that stimulation of this circuit promotes behavioral reinforcement. The findings support a critical role for pedunculopontine tegmental nucleus glutamate neurotransmission in modulating VTA dopamine neuron activity and behavioral reinforcement.
Copyright © 2017 the authors 0270-6474/17/370038-09$15.00/0.

Entities:  

Keywords:  dopamine; glutamate; optogenetics; pedunculopontine; reward; ventral tegmental area

Mesh:

Substances:

Year:  2017        PMID: 28053028      PMCID: PMC5214635          DOI: 10.1523/JNEUROSCI.3082-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  34 in total

1.  Stimulation of the pedunculopontine tegmental nucleus in the rat produces burst firing in A9 dopaminergic neurons.

Authors:  S J Lokwan; P G Overton; M S Berry; D Clark
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

2.  Afferent-specific AMPA receptor subunit composition and regulation of synaptic plasticity in midbrain dopamine neurons by abused drugs.

Authors:  Cameron H Good; Carl R Lupica
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

3.  Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat.

Authors:  Hui-Ling Wang; Marisela Morales
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

4.  Different pedunculopontine tegmental neurons signal predicted and actual task rewards.

Authors:  Ken-ichi Okada; Keisuke Toyama; Yuka Inoue; Tadashi Isa; Yasushi Kobayashi
Journal:  J Neurosci       Date:  2009-04-15       Impact factor: 6.167

5.  Pedunculopontine tegmental nucleus controls conditioned responses of midbrain dopamine neurons in behaving rats.

Authors:  Wei-Xing Pan; Brian I Hyland
Journal:  J Neurosci       Date:  2005-05-11       Impact factor: 6.167

6.  Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry.

Authors:  A Charara; Y Smith; A Parent
Journal:  J Comp Neurol       Date:  1996-01-08       Impact factor: 3.215

7.  Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat.

Authors:  Gina L Forster; Charles D Blaha
Journal:  Eur J Neurosci       Date:  2003-02       Impact factor: 3.386

8.  Effects of pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement.

Authors:  M C Olmstead; E M Munn; K B Franklin; R A Wise
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

9.  Cell-Type-Specific Control of Brainstem Locomotor Circuits by Basal Ganglia.

Authors:  Thomas K Roseberry; A Moses Lee; Arnaud L Lalive; Linda Wilbrecht; Antonello Bonci; Anatol C Kreitzer
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

10.  The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine.

Authors:  A Bechara; D van der Kooy
Journal:  J Neurosci       Date:  1989-10       Impact factor: 6.167

View more
  22 in total

Review 1.  Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

Authors:  Stephan Steidl; David I Wasserman; Charles D Blaha; John S Yeomans
Journal:  Neurosci Biobehav Rev       Date:  2017-09-23       Impact factor: 8.989

2.  A Signaled Locomotor Avoidance Action Is Fully Represented in the Neural Activity of the Midbrain Tegmentum.

Authors:  Sebastian Hormigo; Bharanidharan Shanmugasundaram; Ji Zhou; Manuel A Castro-Alamancos
Journal:  J Neurosci       Date:  2021-03-31       Impact factor: 6.167

Review 3.  Drive and Reinforcement Circuitry in the Brain: Origins, Neurotransmitters, and Projection Fields.

Authors:  Roy A Wise; Ross A McDevitt
Journal:  Neuropsychopharmacology       Date:  2017-10-06       Impact factor: 7.853

4.  Morphological and electrophysiological properties of serotonin neurons with NMDA modulation in the mesencephalic locomotor region of neonatal ePet-EYFP mice.

Authors:  Renkai Ge; Ke Chen; Yi Cheng; Yue Dai
Journal:  Exp Brain Res       Date:  2019-11-12       Impact factor: 1.972

Review 5.  The pedunclopontine nucleus and Parkinson's disease.

Authors:  Cecilia Tubert; Daniel Galtieri; D James Surmeier
Journal:  Neurobiol Dis       Date:  2018-08-29       Impact factor: 5.996

Review 6.  The Mesencephalic Locomotor Region: Beyond Locomotor Control.

Authors:  Brian R Noga; Patrick J Whelan
Journal:  Front Neural Circuits       Date:  2022-05-09       Impact factor: 3.342

Review 7.  Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu-opioid receptor.

Authors:  Jia-Jia Zhang; Chang-Geng Song; Ji-Min Dai; Ling Li; Xiang-Min Yang; Zhi-Nan Chen
Journal:  MedComm (2020)       Date:  2022-06-22

Review 8.  Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction.

Authors:  Jasper A Heinsbroek; Taco J De Vries; Jamie Peters
Journal:  Cold Spring Harb Perspect Med       Date:  2021-03-01       Impact factor: 6.915

Review 9.  Neurobiology of reward-related learning.

Authors:  Ewa Galaj; Robert Ranaldi
Journal:  Neurosci Biobehav Rev       Date:  2021-02-10       Impact factor: 8.989

10.  Diminished reward responsiveness is associated with lower reward network GluCEST: an ultra-high field glutamate imaging study.

Authors:  Valerie J Sydnor; Bart Larsen; Christian Kohler; Andrew J D Crow; Sage L Rush; Monica E Calkins; Ruben C Gur; Raquel E Gur; Kosha Ruparel; Joseph W Kable; Jami F Young; Sanjeev Chawla; Mark A Elliott; Russell T Shinohara; Ravi Prakash Reddy Nanga; Ravinder Reddy; Daniel H Wolf; Theodore D Satterthwaite; David R Roalf
Journal:  Mol Psychiatry       Date:  2021-01-21       Impact factor: 13.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.